Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes

European Journal of Clinical Investigation

Volumn 38, Issue 2, 2008, Pages 90-96

  Ndrepepa, G ^a   Braun, S ^a   Mehilli, J ^a   Von Beckerath, N ^a   Schomig A ^a,b   Kastrati, A ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acute coronary syndrome; Coronary artery disease; Myeloperoxidase

Indexed keywords

C REACTIVE PROTEIN; CREATININE; HEPARIN; MYELOPEROXIDASE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ARTICLE; BLOOD CHEMISTRY; CARDIAC PATIENT; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SMOKING; ST SEGMENT; ST SEGMENT ELEVATION;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PEROXIDASE; PREDICTIVE VALUE OF TESTS;

EID: 38449115330     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2007.01908.x     Document Type: Article

References (25)

1. Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 2005 25: 1102 11.
2. Podrez EA, Abu-Soud HM, Hazen SL. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 2000 28: 1717 25.
3. Heinecke JW. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. Am J Cardiol 2003 91 (3A 12A 16A.
4. Daugherty A, Dunn JL, Rateri DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994 94: 437 44.
5. Hazen SL, Heinecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 1997 99: 2075 81.
6. Sugiyama S, Kugiyama K, Aikawa M, Nakamura S, Ogawa H, Libby P. Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol 2004 24: 1309 14.
7. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 2001 158: 879 91.
8. Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002 106: 2894 900.
9. Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003 349: 1595 604.
10. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T et al. CAPTURE Investigators. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003 108: 1440 5.
11. Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001 286: 2136 42.
12. Mocatta TJ, Pilbrow AP, Cameron VA, Senthilmohan R, Frampton CM, Richards AM et al. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 2007 49: 1993 2000.
13. Khan SQ, Kelly D, Quinn P, Davies JE, Ng LL. Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction. Heart 2007 93: 826 31.
14. Biasucci LM, D'Onofrio G, Liuzzo G, Zini G, Monaco C, Caligiuri G et al. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol 1996 27: 611 6.
15. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva, World Health Organization, 1999.
16. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988 44: 837 45.
17. Kutter D, Devaquet P, Vanderstocken G, Paulus JM, Marchal V, Gothot A. Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit? Acta Haematol 2000 104: 10 5.
18. Nikpoor B, Turecki G, Fournier C, Theroux P, Rouleau GA. A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J 2001 142: 336 9.
19. Pecoits-Filho R, Stenvinkel P, Marchlewska A, Heimburger O, Barany P, Hoff CM et al. A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. Kidney Int Suppl 2003 84: S172 S176.
20. Asselbergs FW, Reynolds WF, Cohen-Tervaert JW, Jessurun GA, Tio RA. Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease. Am J Med 2004 116: 429 30.
21. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005 352: 1685 95.
22. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002 347: 5 12.
23. Baldus S, Heitzer T, Eiserich JP, Lau D, Mollnau H, Ortak M et al. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Me 2004 37: 902 11.
24. Cavusoglu E, Chopra V, Gupta A, Ruwende C, Yanamadala S, Eng C, et al. Usefulness of the white blood cell count as a predictor of angiographic findings in an unselected population referred for coronary angiography. Am J Cardiol 2006 98: 1189 93.
25. Cavusoglu E, Ruwende C, Eng C, Chopra V, Yanamadala S, Clark LT et al. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome. Am J Cardiol 2007 99: 1364 8.